Back to top

Endocyte, Inc. (ECYT) in Focus: Stock Moves 6% Higher
February 12, 2014

Read MoreHide Full Article

Endocyte, Inc. (ECYT - Free Report) was a big mover last session, as the company saw its shares rally 6% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $11.08 to $14.02 in the past one-month time frame, showed a pick-up yesterday at $13.44.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Endocyte currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other similar-ranked stocks in the healthcare industry include Cambrex Corporation. (CBM - Free Report) , Actelion Ltd. and Gentium S.p.A .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Endocyte, Inc. (ECYT) - free report >>

Cambrex Corporation (CBM) - free report >>

More from Zacks Tale of the Tape

You May Like